Published December 27, 2012
| Version v1
Patent
Open
ANTIBODY-LIGHT FUSION PRODUCTS FOR CANCER THERAPEUTICS
Contributors
Patent applicants:
Description
Antibody-LIGHT fusion products or conjugates stimulate immunity against tumors and eradicate metastases. Tumor-specific antibodies coupled with LIGHT effectively target metastatic tumors and reduces cancer metastases.
Files
US20120328558.pdf
Files
(1.1 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:4d26d90aecfcab3575e69e7e17648109
|
1.1 MB | Preview Download |
Additional details
Identifiers
- Patent number
- US 201213563372 A
- Patent application number
- US 2012/0328558 A1
- Other
- oai:uchicago.tind.io:7889
Dates
- Patent filed
-
2012-07-31